Elanco Animal Health Incorporated Common Stock vs Vanguard Emerging Markets Stock Index Fund ETF — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.92 (market cap $11.26B), while Vanguard Emerging Markets Stock Index Fund ETF trades at $59.74 (market cap $168.50B). The key difference: Vanguard Emerging Markets Stock Index Fund ETF is far larger — about 15× Elanco Animal Health Incorporated Common Stock's market cap, and Vanguard Emerging Markets Stock Index Fund ETF is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 1 Days and Vanguard Emerging Markets Stock Index Fund ETF for 135 Days on average.
| ELAN | VWO | |
|---|---|---|
Market Cap | $11.26B | $168.50B |
Volume | 4,570,386 | 9,650,999 |
Sector | Health | — |
52-Week High | $26.84 | $61.44 |
52-Week Low | $19.76 | $52.42 |
Typical Hold Time | 1 Days | 135 Days |
Enterprise Value | $14.65B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VWO trades at $59.76, down 0.15% on the day, with technical indicators showing a bearish bias as moving averages signal selling pressure. The ETF's emerging markets focus faces headwinds from China's economic slowdown, though AI-driven semiconductor demand in Taiwan provides some offset. Recent institutional buying by firms like Allianz and Alamar Capital suggests confidence in long-term emerging markets exposure despite near-term challenges.
The outlook remains cautious given China's persistent weakness and technical bearish signals, though institutional accumulation and AI infrastructure spending offer potential catalysts. Key risks include concentrated emerging markets exposure and currency volatility, requiring careful position sizing for investors seeking diversification beyond developed markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →